Zeltiq Aesthetics Inc (ZLTQ) 17.90 $ZLTQ
ZELTIQ Announces Conference Call and Webcast of First Quarter 2014 Financial Results to Be Held on April 29, 2014
Marketwire - Tue Apr 15, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its first quarter 2014 financial results on Tuesday, April 29, 2014 after the market close.
Relief for "Thigh Shy" Consumers: CoolSculpting(R) Receives FDA Clearance for Non-Surgical Reduction of Thigh Fat
Marketwire - Mon Apr 14, 7:31AM CDT
ZELTIQ(R) Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that the CoolSculpting procedure has received U.S. Food and Drug Administration (FDA) clearance to treat the thighs with its entire suite of applicators. The CoolSculpting procedure is clinically proven to non-surgically reduce unwanted fat, and is already FDA cleared to treat the abdomen and flanks.
ZELTIQ Announces FDA Clearance to Treat Thighs
Marketwire - Mon Apr 14, 7:30AM CDT
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance to treat the thigh area with its entire suite of applicators. The CoolSculpting procedure is a clinically proven, non-surgical procedure that reduces fat in the treated area for good, and is already FDA cleared to treat the abdomen and flanks.
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Accuray Incorporated (NASDAQ: ARAY), Cerus Corporation (NASDAQ: CERS), Galena Biopharma, Inc. (NASDAQ: GALE), and ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
CoolSculpting(R) Procedure Achieves Strong Podium Presence at ASLMS 2014
Marketwire - Thu Apr 03, 7:00AM CDT
ZELTIQ(R) Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced its CoolSculpting procedure, a non-surgical, clinically proven procedure designed to selectively reduce fat in treated areas using a patented cooling technology, will be featured in 10 podium presentations and 7 e-posters at the American Society for Laser Medicine and Surgery annual conference (ASLMS) in Phoenix, Ariz., April 2-6, 2014. Physicians will be presenting their own data.
ZELTIQ Aesthetics expands its CoolSculpting fat reduction treatment procedure, with launch of new CoolSmooth system
M2 - Mon Mar 24, 3:56AM CDT
Medical technology company ZELTIQ Aesthetics (NASDAQ:ZLTQ) reported on Friday the global launch of its CoolSmooth applicator at the American Academy of Dermatology (AAD) annual meeting in Denver, Colorado, for the non-invasive fat reduction in the abdomen and flank.
ZELTIQ(R) Aesthetics Launches CoolSmooth(TM) Applicator
Marketwire - Fri Mar 21, 7:00AM CDT
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the global introduction of the CoolSmooth applicator, the latest addition to the applicator platform for the CoolSculpting system, at the American Academy of Dermatology (AAD), annual meeting in Denver, Colo. The CoolSmooth applicator features non-vacuum based cooling that easily treats non-pinchable fat bulges, and the comfortable design adjusts to fit each individual patient.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
3 Predictions for the New Week
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 02, 2:00PM CST
I went out on a limb last week , and now it's time to see how that decision played out. I predicted that ZELTIQ Aesthetics would move higher on the week. The company behind the gut-thinning CoolSculpting machines spent all of 2013 boosting...
ZELTIQ to Present at 26th Annual ROTH Conference
Marketwire - Wed Feb 26, 3:05PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to present at the 26th Annual ROTH Conference at the Ritz Carlton in Laguna Niguel, California.
ZELTIQ Aesthetics Announces Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Tue Feb 25, 3:01PM CST
ZELTIQ(R) (NASDAQ: ZLTQ)
10-K: ROPER INDUSTRIES INC
Edgar Online - Fri Feb 21, 2:51PM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and Full Year 2013 Financial Results to be Held on February 25, 2014
Marketwire - Mon Feb 10, 3:05PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its fourth quarter and full year 2013 financial results on Tuesday, February 25, 2013 after the market close.
Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014
Leo Sun, The Motley Fool - Motley Fool - Wed Feb 05, 10:00AM CST
Valeant Pharmaceuticals just announced it will acquire PreCision Dermatology, a maker of dermatology products, for $475 million in cash, along with an additional $25 million sales-based milestone. That acquisition is the latest in a...
ZELTIQ to Present at Leerink Global Healthcare Conference
GlobeNewswire - Mon Feb 03, 3:18PM CST
ZELTIQ, (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Chief Financial Officer, are scheduled to present at the Leerink Global Healthcare Conference at the Waldorf Astoria in New York City.
ZELTIQ(R) Aesthetics to Exhibit at IMCAS 2014
Marketwire - Fri Jan 31, 12:00AM CST
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is showcasing its CoolSculpting system at the International Master Course on Aging Skin (IMCAS) Annual Meeting in Paris, 31 January to 2 February, 2014. The CoolSculpting procedure is a non-invasive, clinically proven procedure designed to selectively reduce fat in problem areas using a patented cooling technology.
Concise Report on the Global Image Sensors Market - Forecasts to 2018
PR Newswire - Wed Jan 29, 1:31PM CST
Research and Markets (http://www.researchandmarkets.com/research/78m6cr/image_sensors) has announced the addition of the "Concise Report on the Global Image Sensors Market - Forecasts to 2018" report to their offering.
ZELTIQ Announces Conference Call and Webcast of First Quarter 2014 Financial Results to Be Held on April 29, 2014
Marketwire - Tue Apr 15, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its first quarter 2014 financial results on Tuesday, April 29, 2014 after the market close.
Relief for "Thigh Shy" Consumers: CoolSculpting(R) Receives FDA Clearance for Non-Surgical Reduction of Thigh Fat
Marketwire - Mon Apr 14, 7:31AM CDT
ZELTIQ(R) Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that the CoolSculpting procedure has received U.S. Food and Drug Administration (FDA) clearance to treat the thighs with its entire suite of applicators. The CoolSculpting procedure is clinically proven to non-surgically reduce unwanted fat, and is already FDA cleared to treat the abdomen and flanks.
ZELTIQ Announces FDA Clearance to Treat Thighs
Marketwire - Mon Apr 14, 7:30AM CDT
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance to treat the thigh area with its entire suite of applicators. The CoolSculpting procedure is a clinically proven, non-surgical procedure that reduces fat in the treated area for good, and is already FDA cleared to treat the abdomen and flanks.
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Accuray Incorporated (NASDAQ: ARAY), Cerus Corporation (NASDAQ: CERS), Galena Biopharma, Inc. (NASDAQ: GALE), and ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
CoolSculpting(R) Procedure Achieves Strong Podium Presence at ASLMS 2014
Marketwire - Thu Apr 03, 7:00AM CDT
ZELTIQ(R) Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced its CoolSculpting procedure, a non-surgical, clinically proven procedure designed to selectively reduce fat in treated areas using a patented cooling technology, will be featured in 10 podium presentations and 7 e-posters at the American Society for Laser Medicine and Surgery annual conference (ASLMS) in Phoenix, Ariz., April 2-6, 2014. Physicians will be presenting their own data.
ZELTIQ Aesthetics expands its CoolSculpting fat reduction treatment procedure, with launch of new CoolSmooth system
M2 - Mon Mar 24, 3:56AM CDT
Medical technology company ZELTIQ Aesthetics (NASDAQ:ZLTQ) reported on Friday the global launch of its CoolSmooth applicator at the American Academy of Dermatology (AAD) annual meeting in Denver, Colorado, for the non-invasive fat reduction in the abdomen and flank.
ZELTIQ(R) Aesthetics Launches CoolSmooth(TM) Applicator
Marketwire - Fri Mar 21, 7:00AM CDT
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the global introduction of the CoolSmooth applicator, the latest addition to the applicator platform for the CoolSculpting system, at the American Academy of Dermatology (AAD), annual meeting in Denver, Colo. The CoolSmooth applicator features non-vacuum based cooling that easily treats non-pinchable fat bulges, and the comfortable design adjusts to fit each individual patient.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
3 Predictions for the New Week
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 02, 2:00PM CST
I went out on a limb last week , and now it's time to see how that decision played out. I predicted that ZELTIQ Aesthetics would move higher on the week. The company behind the gut-thinning CoolSculpting machines spent all of 2013 boosting...
ZELTIQ to Present at 26th Annual ROTH Conference
Marketwire - Wed Feb 26, 3:05PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to present at the 26th Annual ROTH Conference at the Ritz Carlton in Laguna Niguel, California.
ZELTIQ Aesthetics Announces Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Tue Feb 25, 3:01PM CST
ZELTIQ(R) (NASDAQ: ZLTQ)
10-K: ROPER INDUSTRIES INC
Edgar Online - Fri Feb 21, 2:51PM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ZELTIQ Announces Conference Call and Webcast of Fourth Quarter and Full Year 2013 Financial Results to be Held on February 25, 2014
Marketwire - Mon Feb 10, 3:05PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its fourth quarter and full year 2013 financial results on Tuesday, February 25, 2013 after the market close.
Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014
Leo Sun, The Motley Fool - Motley Fool - Wed Feb 05, 10:00AM CST
Valeant Pharmaceuticals just announced it will acquire PreCision Dermatology, a maker of dermatology products, for $475 million in cash, along with an additional $25 million sales-based milestone. That acquisition is the latest in a...
ZELTIQ to Present at Leerink Global Healthcare Conference
GlobeNewswire - Mon Feb 03, 3:18PM CST
ZELTIQ, (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Chief Financial Officer, are scheduled to present at the Leerink Global Healthcare Conference at the Waldorf Astoria in New York City.
ZELTIQ(R) Aesthetics to Exhibit at IMCAS 2014
Marketwire - Fri Jan 31, 12:00AM CST
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is showcasing its CoolSculpting system at the International Master Course on Aging Skin (IMCAS) Annual Meeting in Paris, 31 January to 2 February, 2014. The CoolSculpting procedure is a non-invasive, clinically proven procedure designed to selectively reduce fat in problem areas using a patented cooling technology.
Concise Report on the Global Image Sensors Market - Forecasts to 2018
PR Newswire - Wed Jan 29, 1:31PM CST
Research and Markets (http://www.researchandmarkets.com/research/78m6cr/image_sensors) has announced the addition of the "Concise Report on the Global Image Sensors Market - Forecasts to 2018" report to their offering.
